Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 25.90B | 24.75B | 28.11B | 20.96B | 17.07B | 18.00B |
Gross Profit | 16.05B | 14.87B | 17.98B | 10.14B | 8.56B | 10.71B |
EBITDA | 14.23B | 14.03B | 16.76B | 9.21B | 8.66B | 8.68B |
Net Income | 5.92B | 6.95B | 7.31B | 4.15B | 3.57B | 2.92B |
Balance Sheet | ||||||
Total Assets | 198.83B | 190.14B | 177.49B | 158.94B | 140.91B | 127.68B |
Cash, Cash Equivalents and Short-Term Investments | 1.73B | 1.49B | 2.69B | 1.60B | 639.00M | 1.10B |
Total Debt | 93.19B | 82.33B | 73.21B | 64.97B | 54.83B | 48.09B |
Total Liabilities | 137.90B | 129.28B | 118.47B | 109.50B | 95.24B | 82.75B |
Stockholders Equity | 50.80B | 50.10B | 47.47B | 39.23B | 37.20B | 36.51B |
Cash Flow | ||||||
Free Cash Flow | 8.30B | 4.75B | 1.75B | -1.48B | -277.00M | 224.00M |
Operating Cash Flow | 12.21B | 13.26B | 11.30B | 8.26B | 7.55B | 7.98B |
Investing Cash Flow | -21.68B | -22.26B | -23.47B | -18.36B | -13.59B | -13.70B |
Financing Cash Flow | 9.36B | 7.00B | 12.15B | 12.23B | 5.81B | 6.17B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | 51.08B | 20.68 | 8.39% | 4.46% | 7.60% | 55.99% | |
74 Outperform | 57.26B | 15.68 | 12.22% | 3.47% | 5.84% | 36.33% | |
71 Outperform | 94.15B | 19.80 | 9.50% | 3.47% | 4.07% | 9.94% | |
68 Neutral | $146.37B | 24.77 | 11.84% | 3.12% | 18.80% | -6.73% | |
66 Neutral | 43.84B | 16.48 | 9.61% | 3.64% | 4.46% | 8.68% | |
66 Neutral | 100.98B | 23.70 | 12.59% | 3.18% | 8.53% | -7.53% | |
66 Neutral | $17.65B | 18.10 | 5.60% | 3.62% | 6.62% | 11.55% |